A detailed history of Qube Research & Technologies LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,840,664 shares of BSX stock, worth $168 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,840,664
Previous 159,432 1054.51%
Holding current value
$168 Million
Previous $12.3 Million 1156.39%
% of portfolio
0.23%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $123 Million - $141 Million
1,681,232 Added 1054.51%
1,840,664 $154 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $7.27 Million - $8.39 Million
-107,909 Reduced 40.36%
159,432 $12.3 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $18.7 Million - $22.3 Million
-324,996 Reduced 54.87%
267,341 $18.3 Million
Q4 2023

Feb 13, 2024

SELL
$48.64 - $57.81 $4.37 Million - $5.2 Million
-89,906 Reduced 13.18%
592,337 $34.2 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $59.4 Million - $64.8 Million
-1,184,263 Reduced 63.45%
682,243 $36 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $89.5 Million - $98.4 Million
1,800,833 Added 2742.12%
1,866,506 $101 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $8.22 Million - $9.12 Million
-182,357 Reduced 73.52%
65,673 $3.29 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $9.81 Million - $11.7 Million
248,030 New
248,030 $11.5 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $12.2 Million - $16.2 Million
-344,841 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$40.9 - $45.1 $13.4 Million - $14.7 Million
326,612 Added 1791.72%
344,841 $15.3 Million
Q4 2021

Feb 01, 2022

SELL
$38.07 - $44.87 $3.5 Million - $4.12 Million
-91,811 Reduced 83.43%
18,229 $774,000
Q3 2021

Nov 12, 2021

SELL
$41.23 - $45.88 $5.54 Million - $6.16 Million
-134,270 Reduced 54.96%
110,040 $4.78 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $9.43 Million - $10.8 Million
244,310 New
244,310 $10.4 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $399,679 - $449,540
-11,332 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $14.4 Million - $18.3 Million
-434,959 Reduced 97.46%
11,332 $407,000
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $15.4 Million - $18.8 Million
446,291 New
446,291 $17.1 Million
Q2 2019

Aug 02, 2019

SELL
$34.91 - $42.98 $1.91 Million - $2.35 Million
-54,762 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $1.8 Million - $2.23 Million
54,762 New
54,762 $2.1 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $391,072 - $481,168
-12,325 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $298,096 - $350,760
9,080 Added 279.82%
12,325 $475,000
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $68,683 - $87,824
-2,559 Reduced 44.09%
3,245 $106,000
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $146,260 - $165,646
5,804 New
5,804 $158,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.